| Participant | Employment | Representing | Consultant | Speakers Bureau | Ownership/Partnership/Principal | Personal Research | Institutional, Organizational, or Other Financial Benefit | Expert Witness |
|---|---|---|---|---|---|---|---|---|
| Writing Group | ||||||||
| David E. Winchester, Co-Chair | University of Florida, Division of Cardiology—Professor of Medicine and Radiology | ACC | None | None | None | None | None | None |
| David J. Maron, Co-Chair | Stanford University School of Medicine—Professor of Medicine, Cardiovascular, Director, Preventive Cardiology | ACC | None | None | None | None | None | None |
| Ron Blankstein | Brigham and Women’s Hospital—Associate Director, Cardiovascular Imaging Program, Professor of Medicine, Harvard Medical School | SCCT |
1. Amgen, Inc 2. Caristo Diagnostics 3. Novartis* |
None | None |
1. Amgen, Inc† 2. Novartis |
1. SCCT (Officer) | None |
| Ian C. Chang | Mayo Clinic—Assistant Professor of Medicine, and Georgetown University—Assistant Professor of Medicine | ACC | None | None | None | None | None | None |
| Ajay J. Kirtane | Columbia University Medical Center—Professor of Medicine, Chief Academic Office, Director NYP/Columbia Cardiac Cath | SCAI | 1. IMDS | None | None |
1. Abbott Vascular* 2. Amgen, Inc* 3. Boston Scientific* 4. Cardiovascular Systems, Inc* 5. CSI* 6. Medtronic* 7. Philips/Spectranetics* 8. ReCor Medical* |
None | None |
| Raymond Y. Kwong | Brigham and Women’s Hospital—Director of Cardiac Magnetic Resonance Imaging | SCMR | None | None | None |
1. Alnylam, Inc* 2. MyoKardia, Inc* |
1. SCMR (Officer) | None |
| Patricia A. Pellikka | Mayo Clinic College of Medicine—Professor of Medicine | ASE |
1. Ultromics 2. UpToDate* |
None | None |
1. Bracco† 2. Edwards Lifesciences 3. GE Healthcare† 4. Lantheus Medical Imaging† 5. OxThera† 6. Ultromics |
1. ASE Foundation† 2. National Heart, Lung, and Blood Institute† |
None |
| Jordan M. Prutkin | Washington Medical University—Professor of Medicine | HRS | None | None | None | None | 1. UpToDate* | None |
| Raymond Russell | Alpert Medical School of Brown University—Professor of Medicine | ASNC | None | None |
1. Dicerna* 2. Terns Pharmaceutical* |
None |
1. Dicerna* 2. Terns Pharmaceutical* |
None |
| Alexander T. Sandhu | Stanford University School of Medicine—Instructor of Medicine | ACC | None | None | None | None | None | None |
| Rating Panel | ||||||||
| W. Patricia Bandettini | National Institutes of Health—Medical Officer, Heart Failure & Arrhythmias Branch | SCMR | None | None | None | None | None | None |
| Dennis A. Calnon | Ohio Health Heart and Vascular Physicians—Riverside Methodist Hospital, Cardiac Imaging, Director | ASNC | None | None | None | None | 1. ASNC (Officer) | None |
| Manuel D. Cerqueira | Cleveland Clinic Foundation—Chairman, Department of Molecular and Functional Imaging | ACC Imaging Council | 1. Astellas Pharma* | 1. Astellas Pharma* | None | None | None | None |
| Larry S. Dean | Medicine Regional Heart Center University of Washington School of Medicine—Professor of Medicine and Surgery, Director | ACC | 1. Teleflex | None | 1. Emageon | 1. Edwards Lifesciences* | None | None |
| Milind Y. Desai | Cleveland Clinic Foundation, Heart and Vascular Institute—Professor of Medicine | ACC |
1. Bristol Myers Squibb* 2. Caristo Diagnostics 3. Medtronic |
None | None | None | None | None |
| Howard J. Eisen | Pennsylvania State Heart and Vascular Institute—Medical Director, Advanced Heart Failure, Cardiac Transplant Programs | ACC | None | None | None | None | None | None |
| Stephen E. Fremes | Sunnybrook Health Sciences Centre, Division of Cardiac and Vascular Surgery—Professor, Department of Surgery | ACC | None | None | None | None |
1. Bayer (COMPASS)‡ 2. Bayer (Galileo)‡ 3. Boston Scientific (NeoAcurate II Study)‡ 4. Edwards (The Multidisciplinary, Multimodality but Minimalist [3M] Approach to Transfemoral Transcatheter Aortic Valve Replacement)‡ 5. HLT, Inc (Radiant study)‡ 6. Medtronic (Medtronic TAVR Low Risk)‡ 7. Medtronic (SURTAVI)‡ 8. Medtronic (Evolut-R FORWARD)‡ 9. Bernard Goldman Chair in Cardiovascular Surgery* |
None |
| Mario F.L. Gaudino | Weill Cornell Medical College—Stephen and Suzanne Weiss Professor in Cardiothoracic Surgery, Professor of Cardiothoracic Surgery | STS | None | None | None | None | None | None |
| Linda D. Gillam | Morristown Medical Center, Department of Cardiovascular Medicine—Chair | ASE |
1. Edwards Lifesciences* 2. Egnite Medtronic* 3. Philips* |
None | None |
1. Edwards Lifesciences* 2. Medtronic* |
1. Circulation Imaging (Officer) | None |
| Nicole L. Lohr | Medical College of Wisconsin, Cardiovascular Medicine—Professor of Medicine | AHA | None | None | None | None | None | None |
| Joseph E. Marine | Johns Hopkins University School of Medicine, Cardiovascular Medicine—Professor of Medicine | HRS | None | None | None | None | None | None |
| Khurram Nasir | Houston Methodist DeBakey Cardiology Associates, Preventive Cardiology—Professor of Cardiology | ASPC |
1. Amgen, Inc* 2. Esperion 3. Novartis |
1. Amgen, Inc | None | None | None | None |
| Leslee J. Shaw | Icahn School of Medicine at Mount Sinai Hospital Mount Sinai—Director, Blavatnik Family Women’s Health Research Institute, Professor of Medicine | SCCT | None | None | None | None | None | None |
| Jacqueline E. Tamis-Holland | Icahn School of Medicine at Mount Sinai Hospital Mount Sinai—Director, Women’s Heart NY, Assistant Professor of Medicine, Director, Interventional Cardiology Fellowship | SCAI | None | None | None | None | None | None |
| L. Samuel Wann | Cardiovascular Disease Consultant | ACC | None | None | None | None | None | None |
| John B. Wong | Tufts University School of Medicine—Professor of Medicine | ACC |
1. Informed Medical Decisions Foundation: Healthwise 2. Annals of Internal Medicine (American College of Physicians)* |
None | None | 1. Patient-Centered Outcomes Research Institute (PI)* | 1. United States Preventive Services Task Force (Member) | None |
| Reviewers | ||||||||
| Niti R. Aggarwal | Mayo Clinic—Assistant Professor of Medicine | Lead SSOC Reviewer | None | None | None | None | None | None |
| Daniel S. Berman | Cedars-Sinai Medical Center, Department of Imaging—Director, Cardiac Imaging | ACC Imaging Council & SCCT |
1. Cedars Sinai Medical Center—Software Royalties* 2. General Electronic |
None | None | None | None | None |
| Matthew J. Budoff | Los Angeles Biomedical Research Institute—Program Director, Division of Cardiology | SCCT | 1. Esperion* |
1. Amarin* 2. Amgen, Inc* 3. AstraZeneca Pharmaceuticals* 4. Boehringer Ingelheim Pharmaceuticals* 5. Novo Nordisk* |
None | None | None | None |
| Andrew J. Einstein | Columbia University Irving Medical Center, Department of Medicine—Associate Professor of Medicine in Radiology | ASNC | 1. Actinia | None | None |
1. Canon Medical Systems* GE Healthcare* Roche Medical Systems* W. L. Gore and Associates* Novo Nordisk* |
1. ASNC (Officer)† 2. JACC Imaging (Officer)† 3. Journal of Nuclear Cardiology (Officer)† |
None |
| Victor A. Ferrari | Hospital of the University of Pennsylvania—Professor of Medicine; Associate Director, Cardiovascular Imaging | SCMR | None | None | None | None | 1. Journal of Cardiovascular Magnetic Resonance (Officer)† | None |
| Theodore J. Kolias | University of Michigan Cardiovascular Center—Associate Professor of Medicine | ASE | None | None | None | None | None | None |
| Jonathon Leipsic | University of British Columbia, Department of Radiology—Professor of Radiology and Cardiology | SCCT |
1. CIRCL* 2. MVRX* |
1. GE Healthcare 2. Philips |
1. CIRCL CVI* 2. Heartflow* |
1. Heartflow Inc* |
1. Abbott 2. Boston Scientific 3. Edwards 4. Medtronic |
None |
| Brian Olshansky | University of Iowa Carver College, Division of Electrophysiology—Emeritus Professor of Medicine | HRS | None | None | None | None | 1. AstraZeneca (DSMB) | None |
| Harmony R. Reynolds | NYU Grossman School of Medicine, Department of Medicine—Associate Professor of Medicine | AHA | None | None | None | None | None | None |
| Peter P. Toth | University of Illinois College of Medicine, Division of Cardiology—Adjunct Professor of Medicine | ASPC |
1. Amarin 2. Kowa* |
1. Amgen, Inc* 2. Esperion 3. Amgen, Inc* |
None | None | None | None |
| Howard S. Weintraub | NYU Grossman School of Medicine, Department of Medicine—Clinical Professor of Medicine | ASPC |
1. Amgen, Inc 2. Novartis |
None | None |
1. Akcea* 2. Amarin 3. Amgen, Inc* |
None | None |
| David H. Wiener | Jefferson Medical College, Jefferson Heart Institute—Professor of Medicine | ASE | None | None | None | None | None | None |
| Solution Set Oversight Committee | ||||||||
| RWI and disclosure statements for members of the SSOC can be found here: https://www.acc.org/guidelines/about-guidelines-and-clinical-documents/guidelines-and-documents-task-forces | ||||||||
This table represents relevant relationships of participants with industry and other entities that were reported at the time this document was under development. The table does not necessarily reflect relationships with industry at the time of publication
A person has a relevant relationship IF: the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document, or makes a competing drug or device addressed in the document; or the person or a member of the person’s household has a reasonable potential for financial, professional, or other personal gain or loss as a result of the issues/content addressed in the document
A person is deemed to have a significant interest in a business if the interest represents ownership of ≥ 5% of the voting stock or share of the business entity, or ownership of ≥ $5000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships in this table with no symbol are considered modest (less than significant under the preceding definition). Relationships that exist with no financial benefit are also included for the purpose of transparency. Please refer to http://www.acc.org/guidelines/about-guidelines-and-clinical-documents/relationships-with-industry-policy for definitions of disclosure categories or additional information about the ACC Disclosure Policy for Writing Committees
ACC = American College of Cardiology; AHA = American Heart Association; ASE = American Society of Echocardiography; ASNC = American Society of Nuclear Cardiology; ASPC = American Society of Preventive Cardiology; AUC = appropriate use criteria; HRS = Heart Rhythm Society; SCAI = Society for Cardiovascular Angiography and Interventions; SCCT = Society of Cardiovascular Computed Tomography; SCMR = Society for Cardiovascular Magnetic Resonance; SSOC = Solution Set Oversight Committee
*Significant relationship
†No financial benefit
‡Clinical trial enroller